Provided by Tiger Trade Technology Pte. Ltd.

Oculis

24.69
-0.3000-1.20%
Post-market: 24.690.00000.00%17:20 EDT
Volume:126.15K
Turnover:3.11M
Market Cap:1.43B
PE:-10.37
High:25.09
Open:24.88
Low:24.32
Close:24.99
52wk High:30.68
52wk Low:14.00
Shares:57.81M
Float Shares:44.06M
Volume Ratio:0.53
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3818
EPS(LYR):-2.3426
ROE:-73.45%
ROA:-28.65%
PB:5.81
PE(LYR):-10.54

Loading ...

Chardan Raises Price Target on Oculis Holding to $53 From $51, Keeps Buy Rating

MT Newswires Live
·
Mar 04

Oculis: Strengthened Balance Sheet and Advancing Late-Stage Pipeline Support Buy Rating and Higher $40 Target Ahead of 2026 Pivotal Readouts

TIPRANKS
·
Mar 04

Oculis Holding AG reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 04

Oculis reports Q4 EPS (CHF 0.42c) vs. (CHF 0.67) last year

TIPRANKS
·
Mar 04

Switzerland's Oculis reports wider FY25 net loss

Reuters
·
Mar 04

Oculis Holding Q4 EPS $(0.42) Beats $(0.43) Estimate

Benzinga
·
Mar 04

Press Release: Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update

Dow Jones
·
Mar 04

Oculis Holding AG expected to post a loss of 42 rappen a share - Earnings Preview

Reuters
·
Feb 28

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Feb 28

Guosen Securities Highlights Rapid OCS Technology Growth Driven by AI Transformation, Recommends Focus on Industry Chain Firms

Stock News
·
Feb 27

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

GlobeNewswire
·
Feb 19

Oculis Appoints Katie Kazem as Chief Legal Officer

GlobeNewswire
·
Feb 17

Coherent Dispels "Falling Behind" Concerns with Strong AI Client CPO Order and Robust Earnings

Deep News
·
Feb 05

Holding(s) in Company

GlobeNewswire
·
Feb 03

Holding(s) in Company

GlobeNewswire
·
Jan 31

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jan 22

AI Network Supercycle Extends to 2026, Top Winners Shift from "Easy Zhongtian" to "Zhongtian Taichang"?

Deep News
·
Jan 19

TransMedics Group: Buy Rating Reaffirmed on Durable Growth, OCS Platform Uptake, and Emerging Clinical and Geographic Catalysts

TIPRANKS
·
Jan 15

Oculis Holding (OCS) Is Up 15.3% After FDA Breakthrough Status For Privosegtor In Optic Neuritis

Simply Wall St.
·
Jan 11

Assessing Oculis Holding (OCS) Valuation After Privosegtor’s FDA Breakthrough Therapy Designation

Simply Wall St.
·
Jan 09